Otros dos casos con VIH y cáncer, pacientes en Berlín y Londres, han sido informados previamente como curados en revistas científicas después del procedimiento de alto riesgo.

Now the details of the Duesseldorf patient’s cure have been revealed in the journal Nature Medicine.

The 53-year-old man, whose name has not been released, was diagnosed with HIV in 2008, then three years later with acute myeloid leukaemia, a life-threatening form of blood cancer.

En 2013 he had a bone marrow transplant using stem cells from a female donor with a rare mutation in her CCR5 gene. The mutation has been found to stop HIV from entering cells.

The Duesseldorf patient then ceased antiretroviral therapy for HIV in 2018.

Four years later, consistent testing found no trace of HIV returning in his body.

The study said thatthis third case of HIV-1 cureprovidesvaluable insights that will hopefully guide future cure strategies”.



organización de contratos de investigación

terapia con células madre